510(k)

K073431: FORSURE IFOB DUEL SAMPLE FECAL OCCULT BLOOD TEST DEVICE (FOR PROFESSIONAL AND HOME USE); (FOR PROFESSIONAL); (FOR HOME T

FDA 510(k) · Tianjin New Bay Bioresearch Co., Ltd. · decided Jan 14, 2008

Key facts

510(k) number K073431
Device name FORSURE IFOB DUEL SAMPLE FECAL OCCULT BLOOD TEST DEVICE (FOR PROFESSIONAL AND HOME USE); (FOR PROFESSIONAL); (FOR HOME T
Applicant Tianjin New Bay Bioresearch Co., Ltd.
Product code KHE
Date received Dec 6, 2007
Decision date Jan 14, 2008
Decision Substantially equivalent (SESE)
Submission type Special
Review panel Hematology
Medical specialty Hematology

At a glance

  • None MAUDE adverse event reports
  • 1–9 Recall events
  • None UDI device identifiers (GUDID)
  • None Predicate devices cited
  • None Later submissions citing this device
  • 10–99 510(k)s with this product code
  • No 510(k) summary on file
  • No 510(k) statement on file
  • Not listed On the FDA AI-enabled device list

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

Reading a 510(k)

Decision
SESE means the FDA found the device substantially equivalent to its predicate, so it may be marketed in the United States.
Predicates
Each clearance cites one or more legally marketed devices; the chain of predicates shows where a technology came from.
Product code
The three-letter code sets the device type, class and regulation, and groups competing clearances.
Summary or statement
Applicants file either a 510(k) summary of the safety and effectiveness information or a statement that it is available on request.

About 510(k) premarket notifications

A 510(k) is a premarket submission made to the FDA to demonstrate that a device is substantially equivalent to a legally marketed predicate device.

Source: U.S. Food and Drug Administration (FDA), 510(k) Premarket Notification database · Source date:

Browse all 510(k) premarket notifications